Dehghani S, Rezvani A, Shahriarirad R, Rajabian M, Ziaian B, Fallahi M
Cancer Rep (Hoboken). 2025; 8(3):e70108.
PMID: 40071520
PMC: 11897805.
DOI: 10.1002/cnr2.70108.
Zhao T, Yue Y, Sun H, Li J, Wen Y, Yao Y
Front Med (Lausanne). 2025; 12:1507258.
PMID: 40012977
PMC: 11861088.
DOI: 10.3389/fmed.2025.1507258.
Ni R, Huang Y, Wang L, Chen H, Zhang G, Yu Y
BMC Cancer. 2025; 25(1):124.
PMID: 39844169
PMC: 11756104.
DOI: 10.1186/s12885-024-13268-5.
Chen K, Yin Y, Wang C, Zeng A, Fang X, Abuduwayiti A
Transl Lung Cancer Res. 2024; 13(11):2880-2889.
PMID: 39670011
PMC: 11632419.
DOI: 10.21037/tlcr-24-475.
Guerreiro T, Aguiar P, Araujo A
Port J Public Health. 2024; 42(2):133-158.
PMID: 39469231
PMC: 11498919.
DOI: 10.1159/000538434.
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study.
Li P, Liu S, Wang T, Wang F, Li J, Qi Q
Int J Surg. 2024; 111(1):40-54.
PMID: 39352118
PMC: 11745624.
DOI: 10.1097/JS9.0000000000002101.
Application of artificial intelligence in lung cancer screening: A real-world study in a Chinese physical examination population.
Wu J, Li R, Gan J, Zheng Q, Wang G, Tao W
Thorac Cancer. 2024; 15(28):2061-2072.
PMID: 39206529
PMC: 11444925.
DOI: 10.1111/1759-7714.15428.
Integrating Clinical, Genetic, and Electrocardiogram-Based Artificial Intelligence to Estimate Risk of Incident Atrial Fibrillation.
Kany S, Ramo J, Friedman S, Weng L, Roselli C, Kim M
medRxiv. 2024; .
PMID: 39185529
PMC: 11343245.
DOI: 10.1101/2024.08.13.24311944.
The utility of next-generation sequencing in distinguishing between separate primary lung carcinomas and intrapulmonary metastasis: A case report.
Mantri S, Wallace W, Nieva J
Thorac Cancer. 2024; 15(27):1968-1971.
PMID: 39139011
PMC: 11462925.
DOI: 10.1111/1759-7714.15423.
Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data.
Wei W, Wang Y, Ouyang R, Wang T, Chen R, Yuan X
Ann Surg Oncol. 2024; 31(12):7738-7749.
PMID: 39014163
DOI: 10.1245/s10434-024-15762-3.
[Results of Lung Cancer Screening with Low-dose Computed Tomography
and Exploration of Risk Factors in Guangzhou].
Lu X, Qiu Q, Yang C, Li C, Li J, Xiong S
Zhongguo Fei Ai Za Zhi. 2024; 27(5):345-358.
PMID: 38880922
PMC: 11183313.
DOI: 10.3779/j.issn.1009-3419.2024.101.14.
Screening for lung cancer using thin-slice low-dose computed tomography in southwestern China: a population-based real-world study.
Wu J, Li R, Zhang H, Zheng Q, Tao W, Yang M
Thorac Cancer. 2024; 15(19):1522-1532.
PMID: 38798230
PMC: 11219290.
DOI: 10.1111/1759-7714.15383.
Spatial Resolution Fidelity Comparison Between Energy Integrating and Deep Silicon Photon Counting CT: Implications for Pulmonary Imaging.
Salyapongse A, Kanne J, Nagpal P, Laucis N, Markhardt B, Yin Z
J Thorac Imaging. 2024; 39(6):344-350.
PMID: 38712920
PMC: 11495528.
DOI: 10.1097/RTI.0000000000000788.
Tackling Guideline Non-concordance: Primary Care Barriers to Incorporating Life Expectancy into Lung Cancer Screening Decision-Making-A Qualitative Study.
Kearney L, Bolton R, Nunez E, Boudreau J, Sliwinski S, Herbst A
J Gen Intern Med. 2024; 39(12):2284-2291.
PMID: 38459413
PMC: 11347517.
DOI: 10.1007/s11606-024-08705-x.
Epidemiological Analysis of Global and Regional Lung Cancer Mortality: Based on 30-Year Data Analysis of Global Burden Disease Database.
Ji X, Chen J, Ye J, Xu S, Lin B, Hou K
Healthcare (Basel). 2023; 11(22).
PMID: 37998412
PMC: 10671048.
DOI: 10.3390/healthcare11222920.
Artificial Intelligence in Lung Cancer Screening: The Future Is Now.
Cellina M, Cacioppa L, Ce M, Chiarpenello V, Costa M, Vincenzo Z
Cancers (Basel). 2023; 15(17).
PMID: 37686619
PMC: 10486721.
DOI: 10.3390/cancers15174344.
Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
Li J, Stults C, Liang S, Martinez M
BMC Cancer. 2023; 23(1):809.
PMID: 37644406
PMC: 10463613.
DOI: 10.1186/s12885-023-11256-9.
Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer ≤ 2 cm: a systematic review and patient-level meta-analysis.
Fong K, Chan Y, Chia C, Agasthian T, Lee P
Updates Surg. 2023; 75(8):2343-2354.
PMID: 37563486
DOI: 10.1007/s13304-023-01627-z.
Influenza season influence on outcome of new nodules in the NELSON study.
Lancaster H, Heuvelmans M, de Bock G, Du Y, Mohamed Hoesein F, Nackaerts K
Sci Rep. 2023; 13(1):6589.
PMID: 37085595
PMC: 10121576.
DOI: 10.1038/s41598-023-33672-4.
The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screening.
Zhou N, Deng J, Faltermeier C, Peng T, Mandl H, Revels S
JTCVS Open. 2023; 13:379-388.
PMID: 37063117
PMC: 10091284.
DOI: 10.1016/j.xjon.2022.11.021.